Author:
Kuerzel Ulrich,Krone Volker,Zimmer Manfred,Shackleton Gareth
Publisher
Springer Berlin Heidelberg
Reference63 articles.
1. Affrime MB, Cuss F, Padhi D, Wirth M, Pai S, Clement RP, Lim J, Kantesaria B, Alton K, Cayen MN (2000) Bioavailability and metabolism of mometasone furoate following administration by metered-dose and dry-powder inhalers in healthy volunteers. J Clin Pharmacol 40:1227–1236
2. Baillie TA, Cayen MN, Fouda H, Gerson RJ, Green JD, Grossmann SJ, Klunk LJ, LeBlanc B, Perkins DG, Shipley LA (2002) Drug metabolites in safety testing. Toxicol Appl Pharmacol 182:188–196
3. Baillie TA, Cayen MN, Fouda H, Gerson RJ, Green JD, Grossmann SJ, Klunk LJ, LeBlanc B, Perkins DG, Shipley LA (2003) Reply to the editor (see also Hastings et al. 2003). Toxicol Appl Pharmacol 190:93–94
4. Beumer JH, Beijnen JH, Schellens JHM (2006) Mass balance studies, with a focus on anticancer drugs. Clin Pharmacokinet 45(1):33–58
5. Bu HZ, Pool WF, Wu EY, Raber SR, Amantea MA, Shetty BV (2004) Metabolism and excretion of capravirine, a new non-nucleoside reverse transcriptase inhibitor, aone and in combination with ritonavir in healthy volunteers. Drug Metab Dispos 32(7): 689–698
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Human ADME Study;Drug Discovery and Evaluation: Methods in Clinical Pharmacology;2020
2. The Human ADME Study;Drug Discovery and Evaluation: Methods in Clinical Pharmacology;2017